A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects

NCT00602589 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Levofloxacin oral suspension; Levofloxacin oral solution; and Levofloxacin marketed tablet formulations

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.